Insider · CIK 0001614936
Roger Pomerantz
director
Files at VIRX (Viracta Therapeutics, Inc.), INDP (Indaptus Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | INDP Indaptus Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 11, 2025 |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -500 | $0.50 | $250 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.50 | $125 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.50 | $125 | 0 | Apr 11, 2025 |
| Nov 25, 2024 | VIRX Viracta Therapeutics, Inc. | MOption exercise Common Stock | +9,034 | $0.00 | $0 | 126,478 | Nov 27, 2024 |
| Nov 25, 2024 | VIRX Viracta Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -9,034 | $0.00 | $0 | 18,069 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.